Atlas Trials

Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study

Clinical trial NCT02717949 · TERMINATED

Trial details

NCT number
NCT02717949
Sponsor
University of Texas Southwestern Medical Center
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Liver Disease
Start date
2016-02-25
Primary completion
2017-06-05
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.